Project Name: Construction of Freeze-dried Acanthopanax Powder Spasmolytic Production Line
Cooperation Pattern: cooperation, joint venture
Undertaker: Heilongjiang Wusulijiang Pharmaceutical Company Ltd.
Liaison Person: Wang Shugui
Tel\Fax: 0467-5824888 13904676069
Construction Content : In accordance with GMP authentication standard, the Company plans to newly build 11045 square meters of freeze-dried powder spasmolytic workshop, which will be divided into four production modules. In lornoxicam freeze-dried powder spasmolytic production zone, we plan to construct three new production lines which can annually produce 60 million bottles of freeze-dried powder spasmolytic; in carboplatin liposome freeze-dried powder spasmolytic production zone, we plan to construct one production line which can annually produce 10 million bottles of freeze-dried powder spasmolytic; in freeze-dried acanthopanax powder spasmolytic production zone, plan to construct two production lines which can produce 30 million bottles of freeze-dried powder spasmolytic; the last module is the reserved area of new product development.
Products Market: The products of lornoxicam freeze-dried powder spasmolytic, carboplatin liposome freeze-dried powder spasmolytic and freeze-dried acanthopanax powder spasmolytic all have their independent intellectual property rights and enjoy five-year term of protection, no other enterprise has the right to produce these products during the term , so market prospect is very considerable.
Anticipated Investment and Benefit Analysis:
Total Investment: 103.1 million Yuan (RMB)
Profit: 94.19 million Yuan (RMB)
Tax: 132.24 million Yuan (RMB)
|